• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌肿瘤是结节性硬化症的一个特征吗?一项系统评价。

Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review.

作者信息

Dworakowska Dorota, Grossman Ashley B

机构信息

Barts and the London School of Medicine, Centre for Endocrinology, London EC1M 6BQ, UK.

出版信息

Endocr Relat Cancer. 2009 Mar;16(1):45-58. doi: 10.1677/ERC-08-0142. Epub 2008 Oct 31.

DOI:10.1677/ERC-08-0142
PMID:18978035
Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterised by the development of multiple hamartomas in numerous organs. It is caused by mutations of two tumour suppressor genes, TSC1 on chromosome 9q34 and TSC2 on chromosome 16p13.3, which encode for hamartin and tuberin respectively. The interaction between these two proteins, the tuberin-hamartin complex, has been shown to be critical to multiple intracellular signalling pathways, especially those controlling cell growth and proliferation. TSC may affect skin, central nervous system, kidneys, heart, eyes, blood vessels, lung, bone and gastrointestinal tract. Small series and case reports have documented that in tuberous sclerosis patients many endocrine system alterations might occur, affecting the function of the pituitary, parathyroid and other neuroendocrine tissue. There have been scattered reports of the involvement of such tissue in the pathological process of TSC, but no systematic review as to whether this is a true association. We have therefore systematically assessed all available published literature in this area. We conclude that there may be an association with pituitary and parathyroid tumours, and two recent descriptions of Cushing's disease are especially intriguing. However, the evidence seems more firm in the case of islet cell tumours, particularly insulinomas. As these latter may cause changes in mental state that may be confused with the cerebral manifestations of TSC per se, it is particularly important for physicians working with these patients to be aware of the putative and indeed likely association.

摘要

结节性硬化症(TSC)是一种常染色体显性多系统疾病,其特征是在多个器官中形成多个错构瘤。它由两个肿瘤抑制基因的突变引起,位于9号染色体q34的TSC1和位于16号染色体p13.3的TSC2,它们分别编码错构瘤蛋白和结节蛋白。这两种蛋白质(结节蛋白 - 错构瘤蛋白复合物)之间的相互作用已被证明对多个细胞内信号通路至关重要,尤其是那些控制细胞生长和增殖的信号通路。TSC可能会影响皮肤、中枢神经系统、肾脏、心脏、眼睛、血管、肺、骨骼和胃肠道。小型系列研究和病例报告记录了结节性硬化症患者可能会出现许多内分泌系统改变,影响垂体、甲状旁腺和其他神经内分泌组织的功能。关于此类组织参与TSC病理过程已有零星报道,但对于这是否是一种真正的关联尚无系统综述。因此,我们系统地评估了该领域所有已发表的文献。我们得出结论,可能与垂体和甲状旁腺肿瘤有关,最近对库欣病的两项描述尤其引人关注。然而,在胰岛细胞瘤,尤其是胰岛素瘤方面,证据似乎更确凿。由于后者可能导致精神状态改变,这可能与TSC本身的脑部表现相混淆,因此,治疗这些患者的医生意识到这种假定且确实可能存在的关联尤为重要。

相似文献

1
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review.神经内分泌肿瘤是结节性硬化症的一个特征吗?一项系统评价。
Endocr Relat Cancer. 2009 Mar;16(1):45-58. doi: 10.1677/ERC-08-0142. Epub 2008 Oct 31.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
6
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.

引用本文的文献

1
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing's disease.儿童垂体腺瘤的基因评估及库欣病中USP8相关的基因型-表型相关性
Pituitary. 2025 Aug 14;28(5):92. doi: 10.1007/s11102-025-01557-6.
2
Aryl hydrocarbon receptor interacting protein and syndromic gene variants detected in Turkish isolated pituitary adenoma families by whole exome sequencing.通过全外显子组测序在土耳其孤立性垂体腺瘤家族中检测到的芳烃受体相互作用蛋白和综合征基因变异
Sci Rep. 2025 Jul 7;15(1):24279. doi: 10.1038/s41598-025-08610-1.
3
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes.
神经内分泌肿瘤:胚系遗传学与遗传综合征
Curr Treat Options Oncol. 2025 Jan;26(1):55-71. doi: 10.1007/s11864-024-01288-z. Epub 2025 Jan 17.
4
A Comprehensive Target Panel Allows to Extend the Genetic Spectrum of Neuroendocrine Tumors.一个综合的靶向检测板有助于扩展神经内分泌肿瘤的基因谱。
Neuroendocrinology. 2025;115(5):381-401. doi: 10.1159/000542223. Epub 2024 Nov 13.
5
Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.结节性硬化症中的恶性肿瘤:病例报告及文献复习。
BMC Med Genomics. 2024 May 27;17(1):144. doi: 10.1186/s12920-024-01913-8.
6
[Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management].[神经内分泌肿瘤的临床意义:发病率、症状、诊断、分期、预后因素及其对疾病管理的影响]
Radiologie (Heidelb). 2024 Jul;64(7):536-545. doi: 10.1007/s00117-024-01315-y. Epub 2024 May 22.
7
Defining the Role of mTORC1 in Thyrocytes by Studying the TSC2 Conditional Knockout Mouse Model.通过研究 TSC2 条件性敲除小鼠模型来定义 mTORC1 在甲状腺细胞中的作用。
Thyroid. 2024 Aug;34(8):1047-1057. doi: 10.1089/thy.2024.0053. Epub 2024 May 8.
8
A Woman with Bilateral Pheochromocytoma and Tuberous Sclerosis Complex.一名患有双侧嗜铬细胞瘤和结节性硬化症复合体的女性。
AACE Clin Case Rep. 2023 Dec 8;10(2):41-44. doi: 10.1016/j.aace.2023.12.001. eCollection 2024 Mar-Apr.
9
Approach to the Patient: Insulinoma.患者评估:胰岛素瘤。
J Clin Endocrinol Metab. 2024 Mar 15;109(4):1109-1118. doi: 10.1210/clinem/dgad641.
10
Insulinoma in pediatric tuberous sclerosis complex: a case report.小儿结节性硬化症合并胰岛素瘤:一例报告
Front Pediatr. 2023 Jul 19;11:1216201. doi: 10.3389/fped.2023.1216201. eCollection 2023.